These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


170 related items for PubMed ID: 582010

  • 21. [Changes in contractility parameters, coronary flow and myocardial oxygen consumption following intravenous diltiazem in patients with coronary heart disease].
    Oeff M, Schröder R, Biamino G.
    Z Kardiol; 1984 Nov; 73(11):717-23. PubMed ID: 6523970
    [Abstract] [Full Text] [Related]

  • 22. [Systemic and coronary haemodynamic effects of dobutamine and norepinephrine during metabolic acidosis].
    Schulte-Sasse U, Hess W, Schweichel E, Tarnow J, Brückner JB.
    Anaesthesist; 1981 Sep; 30(9):455-60. PubMed ID: 7283111
    [Abstract] [Full Text] [Related]

  • 23. The effect of dobutamine on cardiac oxygen balance, regional blood flow, and infarction severity after coronary artery narrowing in dogs.
    Tuttle RR, Pollock GD, Todd G, MacDonald B, Tust R, Dusenberry W.
    Circ Res; 1977 Sep; 41(3):357-64. PubMed ID: 890890
    [No Abstract] [Full Text] [Related]

  • 24. Influence of dobutamine on regional myocardial blood flow and ventricular performance during acute and chronic myocardial ischemia in dogs.
    Willerson JT, Hutton I, Watson JT, Platt MR, Templeton GH.
    Circulation; 1976 May; 53(5):828-33. PubMed ID: 1260986
    [Abstract] [Full Text] [Related]

  • 25. Effect of intracoronary infusions of amrinone and dobutamine on segment shortening, blood flow, and oxygen consumption in in situ canine hearts.
    Crystal GJ, Rock MH, Kim SJ, Salem MR.
    Anesth Analg; 1994 Dec; 79(6):1066-74. PubMed ID: 7978428
    [Abstract] [Full Text] [Related]

  • 26. Effects of dobutamine and sulmazol (AR-L115 BS) on myocardial metabolism and coronary, femoral, and renal blood flows: a comparative study in normal dogs and in dogs with chronic volume overload.
    Pouleur H, Marechal G, Balasim H, Van Mechelen H, Ries A, Rousseau MF, Charlier AA.
    J Cardiovasc Pharmacol; 1983 Dec; 5(5):861-7. PubMed ID: 6195477
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Combined inotropic and bradycardic effects of a sodium channel enhancer in conscious dogs with heart failure: a mechanism for improved myocardial efficiency compared with dobutamine.
    Shen W, Gill RM, Jones BD, Zhang JP, Corbly AK, Steinberg MI.
    J Pharmacol Exp Ther; 2002 Nov; 303(2):673-80. PubMed ID: 12388650
    [Abstract] [Full Text] [Related]

  • 30. Transient effects of norepinephrine on myocardial oxygen balance.
    von Restorff W, Bassenge E.
    Pflugers Arch; 1977 Aug 29; 370(2):131-7. PubMed ID: 199885
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Response of the atrial pacemaker to dobutamine.
    Puntoni de Mikulić LE, Márquez MT, Aramendía P.
    Acta Physiol Lat Am; 1977 Aug 29; 27(3):108-13. PubMed ID: 210632
    [Abstract] [Full Text] [Related]

  • 34. Alteration in myocardial oxygen balance during exercise after beta-adrenergic blockade in dogs.
    Heyndrickx GR, Pannier JL, Muylaert P, Mabilde C, Leusen I.
    J Appl Physiol Respir Environ Exerc Physiol; 1980 Jul 29; 49(1):28-33. PubMed ID: 6249780
    [Abstract] [Full Text] [Related]

  • 35. Comparison of the cardiodynamic and metabolic effects of dobutamine with those of norepinephrine and dopamine in the dog isolated heart.
    Simaan JA, Fawaz G, Jabbour K.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Aug 29; 338(2):174-9. PubMed ID: 3185745
    [Abstract] [Full Text] [Related]

  • 36. Effects of S-dobutamine on ischemic myocardium caused by coronary artery narrowing.
    Pollock GD, Bowling N, Tuttle RR, Hayes JS.
    J Cardiovasc Pharmacol; 1994 Jul 29; 24(1):64-73. PubMed ID: 7521492
    [Abstract] [Full Text] [Related]

  • 37. Myocardial oxygen consumption: effects of epinephrine, isoproterenol, dopamine, norepinephrine, and dobutamine.
    Vasu MA, O'Keefe DD, Kapellakis GZ, Vezeridis MP, Jacobs ML, Daggett WM, Powell WJ.
    Am J Physiol; 1978 Aug 29; 235(2):H237-41. PubMed ID: 686191
    [No Abstract] [Full Text] [Related]

  • 38. Effects of inotropic and chronotropic stimuli on acute myocardial ischemic injury. I. Studies with dobutamine in the anesthetized dog.
    Rude RE, Izquierdo C, Buja LM, Willerson JT.
    Circulation; 1982 Jun 29; 65(7):1321-8. PubMed ID: 6804112
    [Abstract] [Full Text] [Related]

  • 39. Haemodynamic effects of dobutamine with special reference to myocardial blood flow. A comparison with dopamine and isoprenaline.
    Stephens J, Ead H, Spurrell R.
    Br Heart J; 1979 Jul 29; 42(1):43-50. PubMed ID: 475933
    [Abstract] [Full Text] [Related]

  • 40. Echocardiographic comparison between prenalterol and dobutamine.
    Wester HA, Oltmanns D.
    Acta Med Scand Suppl; 1982 Jul 29; 659():181-90. PubMed ID: 6127888
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.